Openbookopenbook
Equity
medmix AG(MDMXF)
USD --+0.00%
Reward36Moderate
Risk54Moderate
📊75%Data
Thin -1% profit margin · 2.9% dividend yield · Revenue down 7% YoY
MDMXF
+0.0 · +0.00%
USD · PINK
medmix AG | Industrials
Earnings Deterioration
Market Cap:710.26M
ℹ️
Reward Rating
36
Moderate
Bottom 5% (model universe)
75% data coverage
ℹ️
Risk Rating
54
Moderate
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on MDMXF to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is medmix AG?

medmix AG designs, produces, and sells high-precision devices and services in Switzerland and internationally.

MDMXF · Verdict

Limited reward · elevated risk

MDMXF has limited near-term tailwinds — profitability and growth weigh on the model output.

Based on 88% data coverage

MDMXF · Verdict

What’s working & what to watch

Watchouts 3

  • Profitability25/100

    -2% net margin · -1% ROE

  • Growth28/100

    Revenue +1.9% CAGR

  • Balance sheet32/100

    Current ratio 1.60

Model-based scoring. For information only — not financial advice.

What is medmix AG?

medmix AG designs, produces, and sells high-precision devices and services in Switzerland and internationally. It operates through Healthcare; and Consumer and Industrial segments. The company is listed on the PINK in USA, operating in the Industrials sector, with a market capitalisation of 710.26M, and a P/E ratio of 1740.0x.

Financial Highlights

Investment Breakdown

📈 Growth
Revenue growth is subdued, limiting near-term earnings expansion.
💰 Profitability
Thin or inconsistent margins weigh on earnings quality.
⚠️ Risk
Performance tied to macro conditions — sensitive to interest rate cycles.
💸 Valuation
Premium valuation reflects strong growth expectations already priced in.

OpenBook Logo Analysis

Reward: Moderate (36)

The scoring profile indicates weak reward characteristics across most factors, including momentum and size. Risk indicators are elevated — volatility and macro sensitivity warrant consideration.

For informational purposes only. Not financial advice.

Company Information
SectorIndustrials
Market Cap710.26M
P/E Ratio1740
Dividend Yield2.87%
52 Week High17.4
52 Week Low16.8066
Last AnnualDecember
IPO DateN/A
IncorporatedUSA
Shares Outstanding41M
No. of Employees2,667
IndustrySpecialty Industrial Machinery
ExchangePINK
Beta0.931
CurrencyUSD · Reports in CHF
Websitewww.medmix.swiss
openbook

Stock research for everyday UK investors. Make smarter decisions, faster.

Questions? Email us at contact@openbookanalytics.com

© 2026 Openbook Analytics Ltd · Company No. SC843579 · Registered in Scotland

256-bit encryption GDPR compliant UK data centres

Openbook Analytics Ltd (Company No. SC843579) is registered in Scotland. Registered office: Strathclyde Inspire Hub, University of Strathclyde, Graham Hills Building (Level 6), 50 Richmond Street, Glasgow, G1 1XP. Openbook Analytics is not authorised or regulated by the Financial Conduct Authority (FCA). The content on this platform is provided for general informational and educational purposes only and does not constitute financial advice, investment advice, trading advice, or any other form of advice. You should not treat any content on this platform as a recommendation to buy, sell, or hold any financial instrument. Past performance is not a reliable indicator of future results. The value of investments and the income from them can go down as well as up, and you may get back less than you invest. User-generated content, including community posts and commentary, reflects the personal opinions of individual users, is not verified for accuracy, and does not represent the views of Openbook Analytics Ltd. You should always conduct your own research or consult a qualified, FCA-regulated financial adviser before making investment decisions. Data displayed on this platform may be delayed or inaccurate and is provided "as is" without warranty. Openbook Analytics Ltd accepts no liability for any loss arising from reliance on the information provided.